Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
Cancer is the second leading cause of human death globally. PI3K/Akt/mTOR signaling is
one of the most frequently dysregulated signaling pathways observed in cancer patients that …
one of the most frequently dysregulated signaling pathways observed in cancer patients that …
Mutational drivers of cancer cell migration and invasion
NM Novikov, SY Zolotaryova, AM Gautreau… - British journal of …, 2021 - nature.com
Genomic instability and mutations underlie the hallmarks of cancer—genetic alterations
determine cancer cell fate by affecting cell proliferation, apoptosis and immune response …
determine cancer cell fate by affecting cell proliferation, apoptosis and immune response …
Inferring early genetic progression in cancers with unobtainable premalignant disease
I Leshchiner, EA Mroz, J Cha, D Rosebrock, O Spiro… - Nature Cancer, 2023 - nature.com
Abstract Analysis of premalignant tissue has identified the typical order of somatic events
leading to invasive tumors in several cancer types. For other cancers, premalignant tissue is …
leading to invasive tumors in several cancer types. For other cancers, premalignant tissue is …
[HTML][HTML] Liquid biopsy: Cell-free DNA based analysis in breast cancer
Breast cancer management has witnessed significant advancements, especially in the
diagnosis and treatment response monitoring through the implementation of imaging …
diagnosis and treatment response monitoring through the implementation of imaging …
[HTML][HTML] 5-Fluorouracil in Combination with Calcium Carbonate Nanoparticles Loaded with Antioxidant Thymoquinone against Colon Cancer: Synergistically …
Colon cancer is the third most common cancer worldwide, with high mortality. Adverse side
effects and chemoresistance of the first-line chemotherapy 5-fluorouracil (5-FU) have …
effects and chemoresistance of the first-line chemotherapy 5-fluorouracil (5-FU) have …
The landscape of PIK3CA mutations in colorectal cancer
IA Voutsadakis - Clinical Colorectal Cancer, 2021 - Elsevier
Background Colorectal cancer is one of the most common malignancies in both men and
women. Despite progress in the treatment of the disease, metastatic colorectal cancer …
women. Despite progress in the treatment of the disease, metastatic colorectal cancer …
[HTML][HTML] Mutational landscape of PI3K-AKT-mTOR pathway in breast cancer: implications for targeted therapeutics
W Xiao, G Zhang, B Chen, X Chen, L Wen, J Lai… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background: Comprehensive analysis of PI3K-AKT-mTOR pathway gene alterations in
breast cancer may be helpful for targeted therapy. Methods: We performed targeted …
breast cancer may be helpful for targeted therapy. Methods: We performed targeted …
High-resolution and programmable RNA-IN and RNA-OUT genetic circuit in living mammalian cells
M Zhang, X Zhang, Y Xu, Y Xiang, B Zhang… - Nature …, 2024 - nature.com
RNAs and their encoded proteins intricately regulate diverse cell types and states within the
human body. Dysregulated RNA expressions or mutations can lead to various diseased cell …
human body. Dysregulated RNA expressions or mutations can lead to various diseased cell …
miR-320a in serum exosomes promotes myocardial fibroblast proliferation via regulating the PIK3CA/Akt/mTOR signaling pathway in HEH2 cells
QG Wang, BCY Cheng, YZ He… - Experimental and …, 2021 - spandidos-publications.com
MicroRNAs (miRNAs/miRs) serve an important role in the pathogenesis of chronic heart
failure (CHF). A number of reports have illustrated the regulatory effect of serum exosomal …
failure (CHF). A number of reports have illustrated the regulatory effect of serum exosomal …
PI3KCA Mutations in Uterine Cervix Carcinoma
IA Voutsadakis - Journal of Clinical Medicine, 2021 - mdpi.com
Background: Squamous cervical carcinoma represents an infection-associated malignancy
that produces a high mortality when metastatic or recurrent after primary local treatment …
that produces a high mortality when metastatic or recurrent after primary local treatment …